Menko-Jan de Boer

Showing 1-3 of 3 articles

Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay

Heestermans A, de Boer M, van Werkum J, Mosterd A, Gosselink A, Dambrink J, van Houwelingen K, Koopmans P, Hamm C, Zijlstra F, ten Berg J, van't Hof A

August 30, 2011 | 10.4244/EIJV7I4A73

Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction

de Boer M, Hoorntje J, Gosselink A, Suryapranata H, van't Hof A

May 25, 2010

Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines?

Dambrink J, Debrauwere J, van't Hof A, Ottervanger J, Gosselink M, Hoorntje J, de Boer M, Suryapranata H

April 12, 2010

1

Latest news

EAPCI/ACVC consensus on pVADs, coronary physiology mini focus, a new analysis from the COAPT trial, patient selection for tricuspid interventions and more…

Treatment of secondary mitral regurgitation in patients with heart failure

Marco Metra et al

This Week's JAA's: DLMC in CTO-PCI, Membranous Septum Morphology and TAVI ...

Coronary flow capacity: where to next?

Nils P. Johnson

Joint EAPCI/ACVC expert consensus document on pVADs

EuroIntervention's new impact factor!

STATE OF THE ART

Completeness of Revascularisation in ACS Patients with Multivessel Disease

Valeria Paradies et al.

Valvular disease